FDA warned TKTX Numbing Cream USA that its lidocaine numbing creams are unapproved and misbranded new drugs.
What happened
FDA reviewed the company's website, where the creams are sold in the U.S. without a prescription, rather than conducting an inspection. FDA found the labels state 5% lidocaine, above the 0.5% to 4% range allowed for over-the-counter external pain relievers, and that the Gold and Black versions also contain prilocaine, which is not allowed in any such over-the-counter standard. The labels also promote use before tattooing, piercing and laser procedures, which are not permitted uses for these over-the-counter products.
What FDA found
The creams are new drugs sold without an FDA-approved application, which federal law requires.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)The labels state 5% lidocaine, above the 0.5% to 4% range allowed for over-the-counter external pain relievers.
Section 505G, 21 U.S.C. 355h; OTC Monograph M017The Gold and Black creams contain prilocaine, an ingredient not allowed in this or any over-the-counter drug standard.
Section 505G, 21 U.S.C. 355h; OTC Monograph M017The labels claim use for tattooing, piercing and laser procedures, which are not allowed uses for an over-the-counter external pain reliever.
Section 505G, 21 U.S.C. 355h; OTC Monograph M017The products are misbranded because they are nonprescription drugs that do not meet the requirements for marketing without an approved application.
FD&C Act section 502(ee), 21 U.S.C. 352(ee)FDA said these high-strength numbing creams may be applied over large or broken skin and covered with plastic wrap before cosmetic procedures, which can raise absorption and cause serious injury.
What FDA wants
FDA asks the company to write within 15 working days describing the specific steps taken to fix the violations and prevent them from recurring, with supporting documents, or to explain why it believes the products are legal. If more time is needed, the company must say why and give a completion date.
Who should pay attention
- tattoo studios and artists who apply numbing creams
- cosmetic and microblading clinics that use or recommend these products
- online retailers and distributors selling imported numbing creams
This is a summary. Read the original letter on fda.gov.